Conducting Remote Medical Device QMS Audits Training - Webinar (Recorded)

Why Should You Attend:

US FDA statements and actions indicate the past ways of doing things are no longer be acceptable. Increasingly reports from the field indicate that the Agency is using high-profile cases to drive compliance to smaller companies and suppliers. Pressure for `better science` is only one example. Use of remote or virtual can fill in the gap between actual site visits and a `paper` / questionare audit, for a company's remote sites and low to moderate risk vendors / suppliers. Using the field tested techniques presented in this webinar, a remote or virtual audit can provide much the same results as an on-site audit, but with reduced resources and timelines and still follow the US FDA `models` for company internal and supplier audits.

Each year U.S. FDA CGMP compliance inspections get tougher. In the EU and Asia, companies that pass notified-body inspections / audist with glowing reports fail their first FDA inspection and often also receive Warning Letters. Improvement in a company's internal and vendor audit program, adding remote or virtual audits to the company toolbox can greatly facilitate addressing this increased emphasis. This webinar will look at the basic area of difference in emphasis. Also, these changes / differences in focus have a major impact on individual compliance objectives, efforts and measurements of success. Can remote audits help fill the gap? What are the steps to a successful remote audit? Pre-, during- and post audit? We will furtheer evaluate the chief areas of FDA CGMP compliance inspections and evaluate the actual and anticipated changes in emphasis, and how to better prepare with a company's supplemental remote audit program, as well as harmonize these audits to FDA expectations .